VIVAX
Price
$72.44
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
WPLCX
Price
$17.37
Change
+$0.05 (+0.29%)
Updated
Oct 17 closing price
Net Assets
24.07M
Interact to see
Advertisement

VIVAX vs WPLCX

Header iconVIVAX vs WPLCX Comparison
Open Charts VIVAX vs WPLCXBanner chart's image
Vanguard Value Index I
Price$72.44
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
WP Large Cap Income Plus Institutional
Price$17.37
Change+$0.05 (+0.29%)
VolumeN/A
Net Assets24.07M
VIVAX vs WPLCX Comparison Chart in %
View a ticker or compare two or three
VS
VIVAX vs. WPLCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIVAX is a Buy and WPLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. WPLCX (24.1M). VIVAX pays higher dividends than WPLCX: VIVAX (1.97) vs WPLCX (0.00). VIVAX was incepted earlier than WPLCX: VIVAX (33 years) vs WPLCX (12 years). WPLCX (2.21) is less costly to investors than VIVAX (0.17). VIVAX is a more actively managed with annual turnover of: 9.00 vs. WPLCX (1.51). WPLCX has a lower initial minimum investment than VIVAX: WPLCX (2000) vs VIVAX (3000). WPLCX annual gain was more profitable for investors over the last year : 13.80 vs. VIVAX (4.11). VIVAX return over 5 years is better than : 70.92 vs. WPLCX (49.98).
VIVAXWPLCXVIVAX / WPLCX
Total Expense Ratio0.172.218%
Annual Report Gross Expense Ratio0.172.218%
Fund Existence33 years12 years-
Gain YTD9.19311.45480%
Front LoadN/AN/A-
Min. Initial Investment30002000150%
Min. Initial Investment IRAN/AN/A-
Net Assets208B24.1M863,071%
Annual Yield % from dividends1.970.00-
Returns for 1 year4.1113.8030%
Returns for 3 years42.2867.5063%
Returns for 5 years70.9249.98142%
Returns for 10 years128.3184.44152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
FBIOP6.810.03
+0.44%
Fortress Biotech
HE11.280.01
+0.09%
Hawaiian Electric Industries
SWK67.85-0.06
-0.09%
Stanley Black & Decker
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc